(MedPage Today) – The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered markers linked to Alzheimer’s disease in a pilot study involving two open-label trials. In a year-long study, BCG vaccination induced persistent, trained immunity-like changes in cerebrospinal fluid (CSF), including enhanced innate immune responsiveness, reported Steven Arnold, MD, of Massachusetts Genera…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.